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osting by EAbstract Background: Respiratory syncytial virus (RSV) types A and B and inﬂuenza A and B
cause about 80–90% of viral lower respiratory tract infections. It is impossible to distinguish the
cause of viral respiratory infections by their clinical presentation. Multiplex RT-PCR has a signif-
icant advantage in that it permits the simultaneous ampliﬁcation of several viruses in a single reac-
tion facilitating cost-effective diagnosis and perhaps improved clinical management.
Objectives: In this study, our aim was to determine the prevalence of inﬂuenza A and B, and
RSV types A and B among children with CAP, by the use of the newly developed rapid, accurate,
and pathogen-speciﬁc technique of multiplex RT-PCR in order to accomplish the greatest positive
effect on patient care and health care costs.
Study methodology: This study is a cross-sectional study involving 24 children admitted to the
Children’s Hospital of the Ain Shams University due to severe lower respiratory tract infection
(LRTI). Clinical and radiological assessment of all patients was performed followed by the molec-as Elakad, Nasr City, Cairo,
l.com (M.G.E. Mansour).
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156 T.E. Deraz et al.ular analysis of both respiratory and blood samples of all enrolled patients simultaneously by the
use of the newly available reverse transcription-multiplex PCR technique (RT-m PCR).
Results: Viral pneumonia was detected in one-third of enrolled patients (8/24), with the predom-
inance of respiratory syncytial virus A (4/8), followed by inﬂuenza A virus (3/8) and inﬂuenza B
virus (1/8) while no cases of respiratory syncytial virus B was detected. The same results were iden-
tiﬁed in both blood and respiratory specimens.
Conclusion: Reverse transcription-multiplex PCR technique – multiplex has a signiﬁcant advan-
tage in that it permits the simultaneous ampliﬁcation of several viruses in a single reaction making it
well suited for use in epidemiological studies and to improve etiology-directed clinical management
of viral pneumonia.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Respiratory syncytial virus (RSV) types A and B, inﬂuenza A
and B, and human para-inﬂuenza virus (HPIV) types 1, 2,
and 3 cause about 80–90% of viral lower respiratory tract
infections [1]. It is impossible to distinguish the cause of viral
respiratory infections by their clinical presentation; therefore,
laboratory diagnosis is needed. Viral culture has been thought
to be the ‘‘gold standard’’ for their testing; however, this
method is generally slow, often taking up to 14 days before
the results are available [2]. Viral antigen detection by immuno-
ﬂuorescence (IF) provides rapid results, but it often lacks
sensitivity in detecting some viruses and further conﬁrmation
by viral culture may sometimes be required. Although the
combination of both of these techniques can provide an increase
in the proportion of positive results, it has been reported that a
signiﬁcant number of specimens still remains negative, despite
clinical and epidemiological suspicions of viral infection [3,4].
To overcome these limitations, there has been a keen interest
in the development of new nucleic acid-based assays. Reverse
transcription-PCR (RT-PCR) assays have been shown to be ra-
pid, sensitive, and speciﬁc for the detection of respiratory
viruses [2]. However, mono-speciﬁc RT-PCR assays requiring
the separate ampliﬁcation of each virus of interest are poten-
tially expensive and resource intensive, especially since respira-
tory pathogens may cause similar clinical syndromes. Multiplex
RT-PCRhas a signiﬁcant advantage in that it permits the simul-
taneous ampliﬁcation of several viruses in a single reaction facil-
itating cost-effective diagnosis and perhaps improved clinical
management [5]. In this study, our aim was to determine the fre-
quency of inﬂuenza A and B, and RSV types A and B among
children with CAP, by the use of the newly developed rapid,
accurate, and pathogen-speciﬁc technique of multiplex RT-
PCR in order to accomplish the greatest positive effect on pa-
tient care and health care costs.
2. Patients and methods
2.1. Study setting
This is a cross-sectional observational study performed in the
Children’s Hospital of Ain Shams University.
2.2. Patient enrollment
Childrenwith clinical or radiological suggestions of community-
acquired pneumonia and admitted to the Children’s Hospital of
the Ain ShamsUniversity were enrolled fromDecember 2008 toApril 2009. We excluded patients with bronchial asthma,
chronic lung diseases, pulmonary tuberculosis (TB) and hospi-
tal-acquired pneumonia.
2.3. Clinical samples
Both blood and respiratory samples were collected from all eli-
gible patients after having an informed consent signed by the
parents of the child.
2.4. Sample collection and processing
Respiratory specimens were obtained by the gentle suction of
gastric contents early in the morning, from infants and young
children less than 5 years, by placing a sterile nasogastric tube
of proper size after lubrication with parafﬁn oil. In the case of
difﬁcult suctioning or minimal amount (<2 ml), 5 ml of nor-
mal saline was added for liquefaction, and suction was re-
peated. In children more than 5 years, expectorated sputum
was collected into sterile disposable plates. Both serum and
respiratory samples were placed separately in 4 ml of M4 viral
transport medium in a sterile universal container, and were
transported to the laboratory, on wet ice and stored at
4 C until processed within 24 h. Blood samples were centri-
fuged at 2030·g for 10 min. The supernatant serum was re-
moved and stored at 80 C until further testing.
2.5. Reverse transcription-multiplex PCR
Collected specimens were assessed for both RSV and inﬂuenza
viruses simultaneously. These viruses are sharing some physical
properties during their processing for PCR. RNA extraction:
Total RNA was subsequently extracted using a MagNA Pure
Compact system with MagNA Pure Compact NA isolation
kit 1 according to the manufacturer’s instructions (Roche Ap-
plied Science, Mannheim, Germany; Cat. No. o3730964001).
Ampliﬁcation by RT-PCR was done by Light Cycler-RNA
Ampliﬁcation Kit SYBR Green I (Cat. No. 2015137). The kit
is for one-step RT-PCR using the Light Cycler 2.0 System
(Roche, Germany). Primers were non-labeled forward primers
and biotin labeled reverse primers with horseradish peroxi-
dase-labeled probes according to Liolios et al. [1].
2.6. Statistics
Statistical presentation and analysis of the present study was
conducted, using the mean, standard deviation, analysis of
variance (ANOVA) test and chi-square test by SPSS V.16.
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3.1. Patients’ cohort characteristics
Forty-six percent of the enrolled patients’ ages ranged between
1 and 5 years, 37% of them was in their ﬁrst year of life, while
the minority (17%) was older than 5 years. Fifty-four percent
of enrolled patients was male.
3.2. Viral community-acquired pneumonia and its presentations
The presenting symptoms of patients with viral pneumonia
were indistinguishable from those with non-viral pneumonia.
Cough, expectoration, dyspnea and wheezes were common
presenting symptoms in all studied patients. On the other
hand, high grade fever and toxemia (p= 0.03) were
signiﬁcantly present in patients with non-viral pneumonia,
while diffuse auscultatory ﬁndings of ﬁne crepitations
(p= 0.026) was a signiﬁcant ﬁnding in patients with viral
pneumonia. Preceding upper respiratory tract infections were
evident in the majority of patients with viral pneumonia
(87.5%, p= 0.02). All patients had evidence of radiological
ﬁndings on chest roentgenogram. Patients with viral pneumo-
nia had signiﬁcantly more diffuse areas of consolidation while
patients with non-viral pneumonia had more localized forms
of consolidation (p= 0.03). Total leucocytes count was com-
parable in both groups of patients (p= 0.81). While lympho-
cytes count showed markedly signiﬁcant elevation in patients
with viral pneumonia (p= 0.001), and marked neutrophilia
was found in patients with non-viral pneumonia (p= 0.001)
(Table 1).
3.3. Multiplex reverse transcriptase polymerase chain reaction
and viral pneumonia
Multiplex RT-PCR was positive for the examined viruses in 16
specimens out of 48 (33%), collected from 24 eligible patients.
The results of multiplex RT-PCR were identical for both respi-
ratory and blood samples collected from the same patient.
RSV type A was the most frequent virus among the detected
viruses (8/16 specimens, 50%). Inﬂuenza A virus was found
in 37.5% of specimens (6/16) followed by RSV type B which
was found in two specimens only (12.5). No evidence of Inﬂu-
enza B virus was found among the tested specimens. No obvi-
ous signiﬁcant differences in clinical ﬁndings were found
between patients with RSV and inﬂuenza viral pneumonia.
4. Discussion
Common community-acquired respiratory viruses cause signif-
icant morbidity and mortality in all demographic subsets of
the population. Children are considered among the groups at
highest risk for viral pneumonia-associated morbidity and
mortality. Rapid, accurate, inexpensive point-of-care testing
that is able to detect the majority of clinically indistinguishable
respiratory viruses was a real challenge for physicians to diag-
nose this large group of respiratory pathogens. The main prob-
lems have been the lack of ‘gold standard’ methods for
obtaining viral etiology [6].
In this study, simultaneous detection of aforementioned
viruses by viral multiplex reverse transcriptase PCR was ableto diagnose viral pneumonia in nearly one-third (33%) of
children admitted to the hospital due to severe acute lower
respiratory tract infections (LRTI) and pneumonia. RSV type
A was the most frequent virus (4/24 patients, 17%) among the
detected viruses followed by inﬂuenza A virus (3/24 patients,
12.5%) and RSV type B was found in one patient only
(4%). We believe that the identiﬁcation of these viruses as
causes of respiratory disease in these patients is the ﬁrst step
in determining how frequently they may cause serious prob-
lems and, hence, how hard we should push with accepted treat-
ments such as those for inﬂuenza virus infection (either
empirical or targeted treatment) and more controversial treat-
ments such as those for RSV infections (Ribavirin and RSV
hyper-immune globulin).
The molecular diagnosis of viral respiratory infections has
become commonplace and widely accepted in major medical
centers. This acceptance has been partly due to the signiﬁcant
evidence of dramatic improvements in sensitivity compared to
older methods [7].
Comparable results were found in Nepal, where at least one
viral pathogen was isolated using PCR from the nasopharynx
of 40% of the children with community-acquired pneumonia
during their ﬁrst 3-years of age. However, RSV and inﬂuenza
viruses account for only 26.3% of their patients [8]. Study of
515 Korean children less than 5 years of age; detected 11 respi-
ratory viruses in 312 cases (60.6%) by multiplex PCR assays
[7]. However, respiratory syncytial virus, inﬂuenza virus types
A and B proved to represent 30% of all the study cases of low-
er respiratory tract infection encountered in the ﬁrst year of life
by Kusel et al. [9]. In Mozambique, almost half of the hospi-
talized children (394/807) with clinically severe pneumonia
had at least one respiratory virus detected and the most preva-
lent ones were rhinovirus (41%), adenovirus (21%), and respi-
ratory syncytial virus (11%) [10].
Comparing studies is difﬁcult because pneumonia case def-
initions, study settings and method of case ascertainment, as
well as the age group of the study populations differ. Many
hospital-based studies have had limited observation time,
and some were performed during one or only a few seasons.
In addition, various clinical specimens and diagnostic assays
with different sensitivity and speciﬁcity have been used in order
to identify a varying number of viral agents. This has contrib-
uted to great variations in the reported overall frequency of
viruses detected in children with pneumonia. Moreover, sea-
sonal variations of RSV and inﬂuenza infections in temperate
regions in the southern hemisphere, seemingly differ from that
in sub-tropical and tropical locations with seasonal rainfall.
RSV tended to occur in relation to the rainy season; however,
in locations closer to the equator with perennial rainfall, RSV
activity was almost continuous. Inﬂuenza is also reported to be
detectable throughout the year in tropical and sub-tropical re-
gions with less predictable timing of outbreaks, although there
are reports of a biannual pattern of outbreaks with consider-
able activity between epidemic periods [11].
As known for most of the viral infections, our results
showed a male predominance for viral pneumonia with male
to female ratio 1.2:1 which raised the question of whether
males are more susceptible to the progression of illness and
more vulnerable to severe viral illness. Some researchers con-
sider male sex to be one of the several important host risk fac-
tors for severe viral lower respiratory tract infections [11]. This
Table 1 Clinical and demographic implications of viral pneumonia.
Characteristic Viral pneumonia (n= 8) Non-viral pneumonia (n= 16) Chi-square
n % n % v2 p-Value
History
Upper respiratory infection 7 87.5 6 37.5 5.371 0.020*
Previous admission 4 50 3 18.8 2.521 0.112
Previous pneumonia 2 25 2 12.5 0.600 0.439
Clinical symptoms
Cough 7 87.5 16 100 2.087 0.049*
Expectoration 5 62.5 12 75 0.403 0.445
Dyspnea 6 75 7 43.8 2.087 0.148
Wheeze 5 62.5 10 62.5 0.963 0.055
Clinical signs
Fever 7 87.5 16 100 2.087 0.033*
Rales (sibilant rhonchi) 7 87.5 12 75 0.505 0.477
Bronchial breathing 1 12.5 15 93.8 15.844 0.001*
Fine crepitations 8 100 14 87.5 1.091 0.026*
Decreased air entry 3 37.5 14 87.5 6.435 0.013*
Respiratory distress 8 100 16 100 – –
Radiological pulmonary inﬁltrate
Localized inﬁltrate 1 12.5 11 69 4.325 0.033*
Diﬀuse inﬁltrates 7 87.5 5 31
Hematological ﬁndings
WBC; mean ± SD 10.25 ± 1.85 10.43 ± 1.77 0.234 0.816
Lymphocyte %; mean ± SD 62.25 ± 7.59 30.75 ± 6.83 10.267 0.001*
Neutrophil %; mean ± SD 37.25 ± 7.24 66.37 ± 6.71 9.767 0.001*
* p is signiﬁcant if less than 0.05.
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acute lower respiratory tract infections [12–15].
It is noted in our study that 46% of patients admitted due
to severe viral LRTI were less than 12 months and this may be
explained by the vulnerability of this age group to life threat-
ening diseases. Primary infection is rarely asymptomatic and
re-infections are frequent. In a prospective study in the United
States, around two-thirds of children were infected during their
ﬁrst year of life, and by the age of two, nearly all children had
experienced one infection and nearly half had been infected
twice. Level of passively acquired maternal antibody to RSV
could be an underlying factor in the age of acquisition [16].
High grade fever and cough were the chief presenting clin-
ical ﬁndings in patients with non-viral (bacterial) etiology of
LRTI in this study, while upper respiratory tract infections
were more common in patients with viral LRTI. Korppi et
al. [17] found that wheezing, rales, hypoxemia, dyspnea and
cough are seen in 60–80% of cases with viral and bacterial
pneumonia. Yet, it is difﬁcult to distinguish clinically between
viral and bacterial causes of pneumonia. Fever may fail to set-
tle in primary viral LRTI, while cough becomes more promi-
nent. In contrast, where inﬂuenza or RSV infection is
complicated by bacterial pneumonia, fever may settle initially
but then re-credence [18]. On the other hand, we could not dis-
criminate clinically between RSV or Inﬂuenza infections.
Many studies report no differences in clinical symptoms or
signs between illness episodes caused by type A and B viruses
[19]. While Korppi et al. [17] found that RSV is more often
associated with rhinorrhea, sputum production, and wheezing
and less often associated with gastrointestinal complaints and
fever compared with inﬂuenza [17]. In our study, radiologicalﬁndings of viral pneumonia showed diffuse areas of interstitial
inﬁltrate, while patients with non-viral pneumonia had more
localized forms of consolidation. In a study of 128 ambulatory
children with pneumonia, three observers interpreted a lobular
or segmental consolidation in children with bacterial pneumo-
nia, and diffuse nodular densities or a disseminated reticular
pattern in children with viral pneumonia [20]. Though lympho-
cyte and neutrophil count seemingly differentiated viral from
non-viral pneumonia in our study, total leukocyte count
showed no difference between the two groups. This was in
agreement with Virkki et al. [20], who found that the propor-
tion of patients with an increased WBC (>15.0 · 109/L) was
similar in bacterial and viral pneumonia (48% vs. 47%).
The clinical syndromes or hematological changes associated
with respiratory viruses are frequently indistinguishable from
one another or from bacterial pathogens. Viral illness often
exacerbates underlying conditions and complicating diagnosis.
So multiplex quantitative reverse transcription-polymerase
chain reaction-enzyme hybridization assay (MRT-PCR) can
be used to detect and quantitate RNA of respiratory syncytial
viruses A and B, inﬂuenza viruses A and B, in respiratory spec-
imens in a rapid single test with less cost. This was suggested
early by Liolios et al. [1], who suggested that this MRT-PCR
can provide a highly sensitive and speciﬁc means of the diag-
nostic detection of major respiratory viruses compared to viral
culture and immunoﬂuorescence techniques.
5. Conclusion
Multiplex RT-PCR constitutes a rapid diagnostic tool for the
simultaneous detection of more than one viral agent, making
Simultaneous detection of respiratory syncytial virus types A and B 159this multiplex assay well suited for use in epidemiological stud-
ies and beneﬁcial for a respiratory disease diagnostic service
especially in critical clinical setting. Thereby it limits unneces-
sary antibiotic use, and improves clinical management as a re-
sult of the use of appropriate and directed therapy following
the diagnosis of infection with a speciﬁc virus.
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